Status:
UNKNOWN
Antibodies and Liver Retransplantation
Lead Sponsor:
London Health Sciences Centre
Conditions:
Liver Transplant Failure
Antibody-mediated Rejection
Eligibility:
All Genders
Brief Summary
Despite reports that associate donor specific antibody (DSA) with rejection after liver transplantation, grafts are still allocated according to blood group (ABO) but not human leukocyte antigen (HLA)...
Detailed Description
Despite reports that associate donor specific antibody (DSA) with rejection after liver transplantation, grafts are still allocated according to blood group (ABO) but not human leukocyte antigen (HLA)...
Eligibility Criteria
Inclusion
- Recipients of a second liver transplantation performed at LHSC
Exclusion
- Recipients of ABO incompatible second liver transplantation
- Recipients of multiple organs
Key Trial Info
Start Date :
January 1 1977
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03815864
Start Date
January 1 1977
End Date
January 1 2026
Last Update
January 28 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.